Not going anywhere Head and Neck August 7, 2023 A cross-sectional sampling of nearly 3200 adults at dental appointments reports high-risk HPV is prevalent in 7% of men ages…
Spit shine Head and Neck August 1, 2023 This secondary analysis of the DE-ESCALATE HPV trial reports surveillance with coupled plasma and serum HPV testing is 65% sensitive…
Lighten the load Gynecological February 23, 2023 Top Line: Does cervical tumor HPV-clearance correlate to treatment response to definitive chemoradiation? The Study: It seems to work for…
TOR reform Head and Neck May 3, 2022 Top Line: At ASTRO 2021 we got an ORATOR-2 teaser demonstrating there’s no detriment to (perfect) survival and (perfect) disease…
